Consequently, the expression of MEX3B mRNA in the pretreated melanoma tumors, which downregulated human leukocyte antigen (HLA)-A expression on tumor cells by binding to the 3’ untranslated region, was noted to be higher in non-responders than responders to anti-PD-1 therapy (63). The gene discussed is PDCD1; the disease is melanoma.